Medical News |
- Cancer risk reduced in schizophrenia patients
- Children with ADHD at increased risk for bipolar disorder
- Five-yearly surveillance unnecessary in low-risk colorectal cancer patients
- Rivaroxaban effective, but causes more bleeding than enoxaparin
- Stroke risk declines after cessation of HRT
- Poor physical health may indicate worse breast cancer outcome
- BMI in adolescence predicts CHD and diabetes risk later in life
- Novel lipid parameters no better than conventional measures for CVD risk prediction
- COPD not just a disease among smokers
- BMI in adolescence predicts CHD and diabetes risk later in life
- Increased CV, death risk in diabetics largely due to coexistent hypertension
- Adverse outcome risk lower with metformin than other hypoglycemic agents
- Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics
- Candesartan, amlodipine offer similar benefits for paroxysmal AF with hypertension
- Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics
- OSCAR: Combination antihypertensives in elderly most effective in those with CVD
- RIVAL: Radial access PCI linked to reduced access-site complications
- REMEDIAL II: Hydration system protects kidneys from contrast-induced injury
- Poor physical health may indicate worse breast cancer outcome
- Cardiac glycoside could reduce prostate cancer risk
| Cancer risk reduced in schizophrenia patients Posted: 07 Apr 2011 05:00 PM PDT Results from a Taiwanese study suggest that patients with schizophrenia are less likely to develop most types of cancer than individuals without the mental health disorder. |
| Children with ADHD at increased risk for bipolar disorder Posted: 07 Apr 2011 05:00 PM PDT Children with attention-deficit hyperactivity disorder are at increased risk for developing bipolar disorder, suggest results from an Italian study. |
| Five-yearly surveillance unnecessary in low-risk colorectal cancer patients Posted: 07 Apr 2011 05:00 PM PDT Low-risk patients with a history of less than three non-advanced colorectal adenomas have a similar 5-year colorectal cancer risk to individuals with no history of adenoma, Korean study results indicate. |
| Rivaroxaban effective, but causes more bleeding than enoxaparin Posted: 06 Apr 2011 05:00 PM PDT Rivaroxaban is noninferior in efficacy to enoxaparin for prevention of venous thromboembolism in acutely ill patients, but causes significantly higher rates of bleeding, show results from the MAGELLAN trial. |
| Stroke risk declines after cessation of HRT Posted: 06 Apr 2011 05:00 PM PDT The increased risk for stroke among women taking hormone replacement therapy dissipates soon after stopping treatment, shows follow-up of the Women's Health Initiative. |
| Poor physical health may indicate worse breast cancer outcome Posted: 06 Apr 2011 05:00 PM PDT Improving the physical health of breast cancer survivors may reduce their risk for recurrence and death, researchers reported at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida. |
| BMI in adolescence predicts CHD and diabetes risk later in life Posted: 06 Apr 2011 05:00 PM PDT An elevated body mass index in adolescence, but within the range currently considered normal, increases the risk for coronary heart disease and diabetes later in life, US researchers report. |
| Novel lipid parameters no better than conventional measures for CVD risk prediction Posted: 06 Apr 2011 05:00 PM PDT Results of a US study do not support the routine use of novel lipid parameters to assess future cardiovascular disease risk. |
| COPD not just a disease among smokers Posted: 06 Apr 2011 05:00 PM PDT Research indicates that doctors should not rule out a diagnosis of chronic obstructive pulmonary disease in people who have never smoked. |
| BMI in adolescence predicts CHD and diabetes risk later in life Posted: 06 Apr 2011 05:00 PM PDT An elevated body mass index in adolescence, but within the range currently considered normal, increases the risk for coronary heart disease and diabetes later in life, US researchers report. |
| Increased CV, death risk in diabetics largely due to coexistent hypertension Posted: 06 Apr 2011 05:00 PM PDT Results from a subanalysis of the Framingham Heart Study suggest that the increased risk for death and cardiovascular events known to occur in patients with diabetes is primarily due to concomitant hypertension. |
| Adverse outcome risk lower with metformin than other hypoglycemic agents Posted: 06 Apr 2011 05:00 PM PDT The risk for death and cardiovascular disease is lower among people with Type 2 diabetes treated with metformin monotherapy than with other commonly used insulin secretagogues, study results indicate. |
| Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics Posted: 06 Apr 2011 05:00 PM PDT The angiotensin II receptor blocker valsartan was comparable to the calcium channel blocker amlodipine at reducing blood pressure in Japanese patients with hypertension and diabetes or impaired glucose tolerance, according to results of the NAGOYA HEART study. |
| Candesartan, amlodipine offer similar benefits for paroxysmal AF with hypertension Posted: 06 Apr 2011 05:00 PM PDT Candesartan and amlodipine offer similar anti-arrhythmic benefits for paroxysmal atrial fibrillation associated with hypertension, an open-label trial suggests. |
| Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics Posted: 06 Apr 2011 05:00 PM PDT The angiotensin II receptor blocker valsartan was comparable to the calcium channel blocker amlodipine at reducing blood pressure in Japanese patients with hypertension and diabetes or impaired glucose tolerance, according to results of the NAGOYA HEART study. |
| OSCAR: Combination antihypertensives in elderly most effective in those with CVD Posted: 06 Apr 2011 05:00 PM PDT Elderly hypertensive patients with pre-existing cardiovascular disease derive the most benefit from treatment with a combination of an angiotensin II receptor blocker and a calcium channel blocker, show results from the OSCAR study. |
| RIVAL: Radial access PCI linked to reduced access-site complications Posted: 06 Apr 2011 05:00 PM PDT Both femoral and radial approaches to percutaneous coronary intervention are effective, but use of radial access is associated with a significantly lower rate of vascular access site complications than conventional femoral access, according to results of the RIVAL trial. |
| REMEDIAL II: Hydration system protects kidneys from contrast-induced injury Posted: 06 Apr 2011 05:00 PM PDT A system for aggressively hydrating patients undergoing imaging with contrast media is more effective at preventing acute contrast-induced kidney injury than standard prophylaxis with sodium bicarbonate and N-acetylcysteine, according to results of the REMEDIAL II trial. |
| Poor physical health may indicate worse breast cancer outcome Posted: 06 Apr 2011 05:00 PM PDT Improving the physical health of breast cancer survivors may reduce their risk for recurrence and death, researchers reported at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida. |
| Cardiac glycoside could reduce prostate cancer risk Posted: 05 Apr 2011 05:00 PM PDT The cardiac glycoside digoxin could be used as prostate cancer-prevention therapy, says a transdisciplinary team of researchers that evaluated the association between existing, tested, nonchemotherapy drugs and their effects on prostate cancer. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment